The impact of human immunodeficiency virus (HIV) co-infection on the economic burden of cutaneous leishmaniasis (CL) in Brazil and potential value of new CL drug treatments
Previous
Previous
Predicting support for non-pharmaceutical interventions during infectious outbreaks: a four region analysis
Next
Next